Precision Equilibrium: The 2026 B2B Strategic Roadmap for the Global Betahistine Market
As of early 2026, the global betahistine market has evolved into a cornerstone of the neuro-otological pharmaceutical landscape. Primarily recognized as a potent H3-receptor antagonist and weak H1-receptor agonist, betahistine is the gold standard for managing vestibular disorders. The market is currently undergoing a systemic shift, moving beyond simple symptomatic relief toward integrated therapeutic protocols … Read more